Cristina Cruz Zambrano
Member of the Cancer profiling research line
Email: cristina.cruz@umedicina.cat
ORCID: 0000-0002-6474-7504
Scientific Profile: URECERCA
Cristina Cruz is a lecturer at the University of Vic – Central University of Catalonia (UVic-UCC). Her research focuses on cancer biomarkers of prognosis and treatment response.
She graduated in Biochemistry in 1996 (University of Barcelona) and earned the doctorate in Biochemistry in 2001. In 2006 she graduated in Medicine (University of Barcelona) and is a Medical Oncology specialist since 2011. From 2011 to 2018 she was a clinical and translational investigator at Vall d’Hebron Institute of Oncology (VHIO). She participated in a number of clinical trials in the field of early drug development (Phase I) and Phase II & III clinical trials investigating targeted therapies for hereditary breast and ovarian cancers. As a postdoctoral researcher from VHIO’s Experimental Therapeutics Group, she also developed translational projects to investigate the determinants of treatment response and resistance among BRCA1/2 germline mutation carriers, including the functional biomarker RAD51. In 2019, she joined the Faculty of Medicine at UVic-UCC, where she teaches Human Genetics, Histology, Medical Embryology and Physiology.
My last happenings:
From Subversive Labs to Biodesign Literate Curricula: Rethinking Biodesign Education
Authors: Orcajada M. A., Rognoli V, Crespo-Santiago J, Ordóñez I. Biotechnology design, Cambridge University Press, 2026. Results in Engineering, 2026. DOI:https://doi.org/10.1017/S2977905726100390 Keywords: biodesign; biodesign literacy; subversive; labs; education. Funding: This research was partially funded by the Erasmus+ programme Centres of Vocational Excellence, “Transforming Education Area and Competency Hub for Sustainable Development” (project acronym: TEACH4SD). The content of this publication does not reflect the official opinion of the European Union; responsibility for the information and views expressed lies entirely with the author(s). Read More Biodesign has gained prominence over the past two decades yet remains conceptually hazy and institutionally [...]
TR2Lab Invited at Congresso de Feridas Guarda 2026
Clara Masó Albareda, PhD student at TR2Lab, was invited to participate in the Congresso de Feridas Guarda 2026, held in Guarda, Portugal, on 14–15 October 2026. As part of the scientific programme, Clara delivered an invited lecture in the session “Tempo da Inovação – Hot Topics”, where she presented the latest findings from her doctoral research on regenerative therapies and their potential applications in wound healing. Her presentation provided attendees with an overview of the most recent results of her PhD project and highlighted the ongoing research being conducted at TR2Lab. In addition to the lecture, Clara [...]
Exploring the Potential of Phygital Bone as a Synthetic Surrogate for Forensic Bone Trauma
Authors: Crespo-Santiago, J; Jordana, X; Gesualdo, M; Álvarez, A; Mallafré, H; Otero-Viñas, M; Rzymelka V; Andreu C; Garrido X; Schwab N; Galtés I. Exploring the potential of Phygital Bone as a synthetic surrogate for forensic bone trauma. Scientific Reports, 2026. DOI: https://doi.org/10.21203/rs.3.rs-10206802/v1 Keywords: Health sciences/Anatomy; Physical sciences/Engineering; Physical sciences/Materials science; Health sciences/Medical research; Bone trauma; Synthetic bone surrogate; Forensic trauma reconstruction; Bone biomechanics; 3D-printed bone model. Funding: This research was funded by: AEI Clusters Spanish Ministry for Industry and Tourism (AEI-010500-2024-18), Llavor AGAUR Gencat (2023 LLAVOR 0005), and Proyectos de Generación de Conocimiento, Agencia Estatal de Investigación (PID2021-124112NB-100). Read More [...]
